There was nothing "fluff" about that PR--"fluff" is only applicable when you are talking about companies who have nothing, no intentions of ever having anything and intend to deceive investors as long as they possibly can. Dr. Koos needs not buy anymore time--he has spelled out from the beginning the projected path and it is as plain as day on the timeline.
The PR was a reiteration that they are on schedule and that they are making progress in current pre-clinical trials for the next IND application.
The 30 day approval myth was created by members of this board based on public information that actually should be removed since it lacks some very real and common caveats. That myth was disseminated all over the place in various ways, in multiple languages. The hype created a frenzy and when what was never to be to begin with, wasn't delivered, another frenzy was created. Blame, lies & accusations ensued and people continued to dump their shares, further assisting the brutalization of this sub-penny stock.
Typical human behavior. As sad a reality as that is.
There was nothing fluff about that PR. That PR was a message to the shareholders that the company intends to keep them abreast of all that is transpiring to the best of their ability. There is nothing to mention of Hema that hasn't already been said. They are in wait mode. It is as simple as that. We were made aware of this by Dr. Koos not too long ago already.
BMSN
AI
